THE UK STEM CELL FOUNDATION

Charity overview
Activities - how the charity spends its money
The Key aim of the charity is to address the funding gap that hinders the translation of stem cell research into new treatments that have the potential for direct clinical benefit. The charity supports Universities, medical schools and hospitals in the United Kingdom for the benefit of the general public/mankind.
Income and expenditure
Data for financial year ending 31 December 2023
People

3 Trustee(s)
Employees with total benefits over £60,000
No employees have total benefits over £60k for this charityFundraising
Trading
Trustee payments
What, who, how, where
- Education/training
- The Advancement Of Health Or Saving Of Lives
- The General Public/mankind
- Makes Grants To Organisations
- Provides Advocacy/advice/information
- Sponsors Or Undertakes Research
- Throughout England And Wales
Governance
- 14 June 2005: Standard registration
- PROPOSED NEW STEM CELL RESEARCH CHARITY (Previous name)
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
Trustees
Trustees are the people responsible for controlling the work, management and administration of the charity on behalf of its beneficiaries. Generally trustees are treasurer, chair, board member etc. The trustees are responsible for keeping this list up to date and can do this by updating their details as they happen through the online service
3 Trustee(s)
Name | Role | Date of appointment | Other trusteeships | Reporting status of other trusteeships | ||||
---|---|---|---|---|---|---|---|---|
Trevor Michael Phillips | Trustee | 02 January 2025 |
|
|
||||
JAMES TAYLOR | Trustee | 08 October 2012 |
|
|
||||
PROFESSOR TREVOR MERVYN JONES CBE | Trustee |
|
|
Financial history
Financial period end date
Income / Expenditure | 31/12/2019 | 31/12/2020 | 31/12/2021 | 31/12/2022 | 31/12/2023 | ||
---|---|---|---|---|---|---|---|
|
Total gross income | £643.50k | £285.25k | £52.78k | £28.37k | £122.40k | |
|
Total expenditure | £279.87k | £344.15k | £317.67k | £320.72k | £380.27k | |
|
Income from government contracts | N/A | N/A | N/A | N/A | N/A | |
|
Income from government grants | N/A | N/A | N/A | N/A | N/A | |
|
Income - Donations and legacies | £638.96k | N/A | N/A | N/A | N/A | |
|
Income - Other trading activities | £0 | N/A | N/A | N/A | N/A | |
|
Income - Charitable activities | £0 | N/A | N/A | N/A | N/A | |
|
Income - Endowments | £0 | N/A | N/A | N/A | N/A | |
|
Income - Investment | £0 | N/A | N/A | N/A | N/A | |
|
Income - Other | £4.55k | N/A | N/A | N/A | N/A | |
|
Income - Legacies | £614.98k | N/A | N/A | N/A | N/A | |
|
Expenditure - Charitable activities | £65.68k | N/A | N/A | N/A | N/A | |
|
Expenditure - Raising funds | £214.19k | N/A | N/A | N/A | N/A | |
|
Expenditure - Governance | £6.15k | N/A | N/A | N/A | N/A | |
|
Expenditure - Grants institution | £0 | N/A | N/A | N/A | N/A | |
|
Expenditure - Investment management | £0 | N/A | N/A | N/A | N/A | |
|
Expenditure - Other | £0 | N/A | N/A | N/A | N/A |
Accounts and annual returns
Title | Reporting year | Date received | Received | Download |
---|---|---|---|---|
Annual return | 31 December 2023 | 15 November 2024 | 15 days late | |
Accounts and TAR | 31 December 2023 | 15 November 2024 | 15 days late | Download Open in new window |
Annual return | 31 December 2022 | 04 October 2023 | On Time | |
Accounts and TAR | 31 December 2022 | 04 October 2023 | On Time | Download Open in new window |
Annual return | 31 December 2021 | 09 January 2023 | 70 days late | |
Accounts and TAR | 31 December 2021 | 09 January 2023 | 70 days late | Download Open in new window |
Annual return | 31 December 2020 | 31 October 2021 | On Time | |
Accounts and TAR | 31 December 2020 | 31 October 2021 | On Time | Download Open in new window |
Annual return | 31 December 2019 | 07 December 2020 | 37 days late | |
Accounts and TAR | 31 December 2019 | 12 March 2021 | 132 days late | Download Open in new window |
Governing document
It is not the full text of the charity's governing document.
MEMORANDUM AND ARTICLES AS AMENDED BY SPECIAL RESOLUTION(S) DATED 13/06/2005 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 21/02/2011
Charitable objects
3. THE CHARITABLE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE THE PRESERVATION, PROMOTION AND ADVANCEMENT OF HUMAN HEALTH AND WELFARE AND THE ADVANCEMENT AND PROMOTION OF KNOWLEDGE AND EDUCATION FOR THE BENEFIT OF THE PUBLIC BY: 3.1 ENHANCING AND PROMOTING KNOWLEDGE OF AND ENGAGING IN, FUNDING AND SUPPORTING RESEARCH INTO THE MECHANISMS OF CELL DEGENERATION, REGENERATION AND MALFUNCTION AND THEIR LINKS TO DEGENERATIVE AND OTHER DISEASES, DISABILITIES, DISORDERS AND CONDITIONS IN RESPECT OF WHICH STEM CELL RELATED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS OR TECHNOLOGIES MIGHT BE BENEFIT; 3.2 ENGAGING IN, FUNDING AND SUPPORTING RESEARCH INTO STEM CELL AND STEM CELL-BASED OR DERIVED METHODS AND TECHNOLOGIES, WITH A VIEW TO DISCOVERING, INVENTING, IMPROVING, DEVELOPING, PRODUCING AND APPLYING MEDICINE, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES, INCLUDING THE TRANSLATION OF PURE RESEARCH INTO OUTPUTS TO A STANDARD SUSCEPTIBLE OF CLINICAL TRIALS WITH A VIEW TO ESTABLISHING THE EFFICACY AND SUPPORTING THE CLINICAL DEVELOPMENT OF MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES CAPABLE OF APPLICATION; 3.3 EDUCATING AND INFORMING THE PUBLIC IN RELATION TO STEM CELLS AND THE EFFICACY OF STEM CELL BASED OR DERIVED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES; AND 3.4 PROMOTING THE ETHICAL USE OF STEM CELLS WHETHER IN RESEARCH, DEVELOPMENT OR OTHERWISE AND THE ETHICAL USE AND PRODUCTION OF STEM CELLS AND STEM CELL BASED OR DERIVED MEDICINES, TREATMENTS, CURES, DIAGNOSTICS, APPLICATIONS, THERAPIES, PRODUCTS AND TECHNOLOGIES AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES AND THE APPROPRIATE REGULATION AND MANAGEMENT THEREOF AND EDUCATING AND INFORMING THE PUBLIC IN RELATION TO SUCH MATTERS.
Area of benefit
NATIONAL AND OVERSEAS
Contact information
- Address:
-
3rd floor 45 Albemarle Street
London
W1S 4JL
- Phone:
- 02045724151
- Email:
- info@ukscf.org
- Website:
Tell us whether you accept cookies
We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.
We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.
Thank you for your feedback. Do you have 5 minutes to tell us what you think of this service?Open in new window